|

The Role of POLE Mutation in High Risk Endometrial Cancer.

RECRUITINGSponsored by Far Eastern Memorial Hospital
Actively Recruiting
SponsorFar Eastern Memorial Hospital
Started2025-09-01
Est. completion2026-12-31
Eligibility
SexFEMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07114653

Summary

The actual role of POLE mutations in high-risk endometrial cancer is undetermined. The main question it aims to answer is: What is the prevalence of POLE mutations in high-risk endometrial cancer case? What is the impact of POLE mutations in real world high-risk endometrial cancer case?

Eligibility

Sex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

* women with high-risk for recurrent endometrial cancer

Exclusion Criteria:

* Nil

Conditions2

CancerEndometrial Neoplasms

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.